AAMI Board Gains Three Medtech Experts

NEWS TRENDS

Three experts in medical technology have been elected to the board of directors of the Association for the Advancement of Medical Instrumentation (AAMI; Arlington, VA).

David Francoeur is vice president of operations at TriMedx (Indianapolis), a provider of clinical engineering services. He has more than 24 years of experience in the areas of environmental services, plant operations, and clinical engineering. Since 2004, he has served on the Executive Committee of AAMI's Technology Management Council. Francoeur also serves on the editorial board of AAMI's journal, Biomedical Instrumentation & Technology.

Joel R. Gorski, PhD, is director of business development for NAMSA (Northwood, OH), which evaluates medical devices and materials for safety and efficacy. He is active on numerous AAMI working groups. He has been cochair of the AAMI chemical indicators working group (AAMI/ST/WG 06) since 1996 and cochair of AAMI's working group on resistometers (AAMI/ST/WD 91) since 1999. Gorski is also a member of MD&DI's editorial board.

Leighton Hansel is director of regulatory affairs for the medical group at Abbott (Abbott Park, IL). Prior to joining Abbott, he served at FDA, including 13 years as a division director in CDRH. He has been involved in standards work at AAMI for the past 10 years. His goal is to convince more executives to support standards efforts.

“AAMI's place at the forefront of the medical device field is in many ways directly attributable to the talents and dedication of the individuals who have served on its board of directors over the last 40 years,” said AAMI President Michael J. Miller. “With Leighton, Joel, and Dave, who have already made significant contributions to AAMI and to the industry, AAMI's future is in very capable hands. Their talents and insights will be key assets in facing the challenges that lie ahead for the association and for the field.”

Copyright ©2007 Medical Device & Diagnostic Industry